NTx R

Related by string. * NTX : NTx ® -# . NTx ® . NTx TM -# . XR NTX . NTx / Rs . red . Rd . R. . ring . Ring . RS . RD . RED . Red . rd . RING . rs . RER . r. . r : MS RD . Rs #.# [005] . Bill Frist R Tenn . R Ind . RED FLAG WARNING WHICH . Toys R Us . Ford Focus RS . Mike Huckabee R-Ark. . Red Bull Racing . 3 rd . Abu Dhabi Focus RS . Red Cross Blood Donor . Boston Red Sox . Red Hat Enterprise . Red Cross Disaster Relief . Red Bull Sebastian Vettel * *

Related by context. All words. (Click for frequent words.) 83 NTx ® 67 Holes SP# 67 Schizophrenia Bulletin 65 Holes DDHC 63 NTx 62 Acta Psychiatrica Scandinavica 61 § § #-#-# [002] 60 § § #-#-# [001] 56 Clinical Psychopharmacology 55 Respir Med 55 clinical pharmacology studies 54 sargramostim 54 antithrombotic therapy 54 holes DDHC 54 ADAGIO study 54 Trust Ser 54 EndoTAG ® 53 AEGR 53 NLX P# 53 CHASE POINTS 53 guideline concordant 53 CIMZIA ™ 53 Ceplene/IL-2 52 CIMZIA TM 52 preclinical efficacy 52 ER CHOP 52 INVEGA ® 52 BCIRG 52 acute ischemic stroke 52 Nonclinical 51 BEXXAR Therapeutic Regimen 51 chemoradiation therapy 51 ACTIVE W 51 Capesaris 51 LONG BEACH Sportfishing Berth 51 CCX# B 51 clevidipine 51 Acute Ischemic Stroke 51 suppl. 50 BENICAR HCT 50 phase Ib 50 CCX# 50 virological response 50 ELACYT 50 oral ridaforolimus 50 Allovectin 7 ® 50 somatostatin analog 50 EchoCRT 50 nonpharmacologic 50 EndoTAG TM -1 50 abiraterone acetate 50 tocilizumab 50 Phase #/#a 50 MVax 50 Lu AA# 50 abstr 50 Phase #b/#a 50 pharmacokinetic PK study 50 desvenlafaxine 50 CALGB 50 desvenlafaxine succinate 50 tipranavir r 50 Zevalin consolidation 50 pharmacological treatments 50 clinically meaningful improvement 49 APTIVUS 49 phase IIa clinical 49 oral anticoagulation 49 adjuvant systemic 49 Lofexidine 49 azilsartan medoxomil 49 phase IIb clinical 49 adenoma recurrence 49 CBLC# 49 Kahalalide F 49 #:# -# [004] 49 dose escalation phase 49 guanfacine extended release 49 NJSA #:#-# [003] 49 RhuDex ® 49 Pharmacologic 49 liposomal formulation 49 IRESSA 49 APTIVUS r 49 blinded placebo controlled 49 RhuDex 49 RTOG 49 viral kinetic 49 metastatic RCC 49 tesmilifene 49 CERE 49 fosbretabulin 49 ReN# 49 MYDICAR 49 SAN DIEGO Helgren Oceanside 49 ABVD 49 Phase 2b study 49 phase IIIb 49 Arch Surg 49 dose escalation clinical 49 atherosclerotic renal artery stenosis 49 Traficet EN 49 UPLYSO 49 CHAMPION PCI 49 Phase III randomized controlled 49 DP b# 49 Cethromycin 49 VBLOC Therapy 49 Cladribine tablets 49 MEVACOR 49 tapentadol ER 48 TroVax ® 48 insulin detemir 48 RE LY ® 48 warfarin therapy 48 NeuroStar TMS Therapy 48 ROCKET AF 48 EOquin TM 48 AGILECT ® 48 PREZISTA ritonavir 48 doxorubicin docetaxel 48 Acute Coronary Syndromes ACS 48 PFO migraine 48 Pharmacokinetic studies 48 celgosivir 48 MYTHOS trial 48 confirmatory Phase III 48 Archexin 48 IFN alfa 48 Initiated Phase 48 OXNARD Channel 48 BENICAR 48 -# -# -# [002] 48 paclitaxel Taxol R 48 E1 INT TM 48 SUCCEED trial 48 sunitinib malate 48 -# -# -# -# 48 alteplase 48 PROMACTA 48 Perforomist Inhalation Solution 48 pain palliation 48 BEXXAR therapeutic regimen 48 Glybera R 48 NasalFent 48 cortical stimulation 48 treatment naive genotype 48 Vernakalant 48 glatiramer acetate 48 Vectibix monotherapy 48 placebo controlled clinical 48 androgen suppression 48 AZOR 48 HF ACTION 48 Allovectin 7 48 aldosterone antagonists 48 Thrombolysis 48 CIPN 48 SUTENT ® 48 EECP therapy 48 Anavex #-# 48 controlled multicenter Phase 48 antidepressive 48 acute mania 48 OLYMPIA registry 48 Ketotransdel 48 TAXUS Liberté stent 48 Zemplar Capsules 48 Cinacalcet HCl 48 J Pharmacol Exp Ther 48 Elitek 48 GW# [003] 48 DUROS 48 jason.hovet @ thomsonreuters.com 48 reteplase 48 YONDELIS 48 Bookmaker odds 47 Valdoxan 47 CINTREDEKIN BESUDOTOX 47 synthetic retinoid 47 Ziprasidone 47 ONTARGET 47 pharmacologic treatments 47 lipid lowering therapy 47 mitomycin 47 Telintra 47 GSK# [001] 47 PROCHYMAL 47 BrachySil TM 47 tipranavir 47 SYN# 47 NSABP 47 multicentre randomized 47 Augment Injectable 47 TMS Therapy 47 Crit Care Med 47 Islands Sportfishing 47 Teriflunomide 47 #:# -# [005] 47 HORIZONS AMI trial 47 MoxDuo 47 antioxidant supplementation 47 SSRI SNRI 47 multicenter Phase 47 DEB# 47 Cardiotoxicity 47 divalproex sodium 47 Behavior Therapy 47 Randomised 47 Phase Ib study 47 Troxatyl 47 randomizing patients 47 vidofludimus 47 HBeAg negative patients 47 pemetrexed Alimta 47 canakinumab 47 SparVax TM 47 Refractory Angina 47 PEGylated interferon 47 fludarabine cyclophosphamide 47 TAXOTERE R 47 Stenting Trial 47 Dabigatran etexilate 47 Neuroreport 47 XIENCE V stent 47 CLL SLL 47 HuMax EGFr 47 Nephrol Dial Transplant 47 Intervention Effectiveness 47 ZYBRESTAT TM 47 PREOS R 47 MADRS score 47 Cell Mol Biol 47 bardoxolone 47 recurrent malignant glioma 47 Phase Ib II 47 Randomized controlled 47 trodusquemine 47 ORMD 47 regorafenib 47 Ceflatonin R 47 beta 1a 47 -# [004] 47 CALGB # [002] 47 Phase IIb III 47 Psychiatric Services #:#-#,# 47 Cysteamine 47 Vascugel ® 46 #:#-#,# Medline 46 CIMZIA R 46 platelet inhibitor 46 HCD# [002] 46 SEK -# 46 IFN α 46 ASCT 46 poststroke depression 46 J Physiol 46 antidepressant efficacy 46 concurrent ITP 46 Catena ® 46 MEND CABG II 46 deferoxamine 46 Natalizumab 46 Onrigin TM 46 AIR2 Trial 46 -8 -9 46 PegIFN RBV 46 Meta analyzes 46 Solesta 46 stated Michelle Berrey 46 repetitive transcranial magnetic stimulation 46 MYDICAR ® 46 randomized Phase IIb 46 periprocedural 46 AFRS TM 46 pegylated liposomal doxorubicin PLD 46 paricalcitol 46 AGGRASTAT ® 46 ALT elevation 46 Cotara 46 hypogonadal men 46 Kaplan Meier analysis 46 Cloretazine 46 Phase #b/#a clinical 46 PDE4 inhibitor 46 LCP Tacro TM 46 XYOTAX TM 46 volociximab 46 neoadjuvant 46 eluting stent 46 noninferior 46 paclitaxel poliglumex 46 mapatumumab 46 PFO closure 46 Lucentis ranibizumab Genentech 46 agomelatine 46 Cethrin 46 Gabapentin GR 46 APEX PD 46 RHEO 46 Cognitive behavioral 46 Dalbavancin 46 Raptiva r 46 Aeroquin 46 DAPT 46 Genz # 46 sirolimus eluting stents 46 Xelox 46 empirically validated 46 Dacogen decitabine 46 randomized #:#:# 46 OVER UNDER PICK RECORD 46 Major Depressive Disorder 46 comparator arm 46 Phase 1a 46 divalproex 46 Aflibercept 46 triple nucleoside 46 TroVax 46 pharmacological therapies 46 Multaq R 46 Advanced Heart Failure 46 BRILINTA 46 MoxDuo TM IR 46 Phase III HEAT 46 BLP# Liposome Vaccine 46 Randomized Evaluation 46 neuropsychological assessment 46 methotrexate monotherapy 46 intravenous dosing 46 pharmacokinetics PK 46 MDRD 46 Fabry Disease 46 metastatic renal cell carcinoma 46 Phase IIa trials 46 multicenter randomized controlled 46 novel oral anticoagulant 46 subthreshold depression 46 APEX AMI 46 neurocognitive function 46 TREANDA 46 Xyfid 46 HuMax CD4 46 pharmacological approaches 46 MICARDIS ® 46 MoxDuo IR 46 highly emetogenic chemotherapy 46 trastuzumab Herceptin R 46 Symadex 46 DX JUN# 46 pharmacodynamic PD 46 catheter occlusion 46 lorcaserin Phase 46 biologic DMARD 46 MIST II 46 BACcel TM 46 carboplatin paclitaxel 46 Simulect 45 eplerenone 45 ENDEAVOR IV 45 prospective nonrandomized 45 SIMPADICO 45 randomized controlled Phase 45 Cloretazine R VNP#M 45 GEM OS2 45 Proxinium TM 45 Aplidin R 45 OSV newbuild program 45 peginterferon alpha 45 relapsing multiple sclerosis 45 inhaled AAT 45 symptomatic hyponatremia 45 Phase Ib clinical 45 LT NS# 45 NSABP B 45 Lucanix 45 immunotherapeutic vaccine 45 CLBP 45 Litx 45 APEX AMI trial 45 EDEMA3 45 -#.# log# 45 Phase Ib 45 pyridostigmine 45 Xanafide 45 Increlex R 45 XIENCE V PROMUS Stent 45 zalutumumab 45 dose escalation Phase 45 SSRI citalopram 45 ThermoDox R 45 RAV# 45 neuroleptic 45 Abilify aripiprazole 45 pegylated liposomal doxorubicin 45 aromatase inhibitors AIs 45 SportsBook.com offers 45 KRN# 45 β blocker 45 myoblast therapy 45 melphalan prednisone 45 Parathyroid Hormone 45 LCP AtorFen 45 oral prednisolone 45 Intravitreal 45 Phase IIIb clinical 45 HYVET 45 ibandronate 45 CRRT 45 HBeAg + 45 randomized controlled trials RCTs 45 leukotriene receptor antagonist 45 Eur J Pharmacol 45 Sycrest 45 topically administered 45 Phase 2b kidney transplant 45 cathepsin K inhibitor 45 MEND CABG 45 intra arterial 45 Interpersonal psychotherapy 45 cariprazine 45 double blinded randomized 45 dual antiplatelet 45 FOR FURTHER INFORMATION ABOUT 45 -Cybernet SlashSupport 45 analgesic efficacy 45 ziconotide 45 adjuvant endocrine therapy 45 randomized discontinuation 45 Kamada AAT 45 cetrorelix 45 NovoSeven ® 45 BRIM2 45 salmeterol fluticasone 45 Psychopharmacology 45 Liprostin 45 Chemophase 45 J Clin Psychiatry 45 BAL# [002] 45 multicenter randomized Phase 45 TMC# C# 45 acute PAO 45 NOX E# 45 orally administered inhibitor 45 quetiapine 45 nab paclitaxel 45 pharmacotherapies 45 Initiate Phase 45 ADVANCE PD 45 TAXUS ATLAS 45 Phase IIA 45 androgen deprivation 45 BARI 2D 45 ZYBRESTAT 45 VBLOC TM vagal blocking 45 Mycophenolate Mofetil 45 solithromycin 45 fibromyalgia syndrome 45 phenelzine 44 everolimus eluting stents 44 Oxycyte 44 docetaxel Taxotere ® 44 Fibrillex TM 44 Nat Rev Neurosci 44 Vascugel 44 randomized multicenter 44 #:# randomization 44 inhaled treprostinil 44 direct thrombin inhibitors 44 PROMETA 44 nonmetastatic prostate cancer 44 paclitaxel carboplatin 44 Onconase 44 receptor antagonism 44 psychodynamic psychotherapy 44 paliperidone palmitate 44 cognitive behavioral therapies 44 donepezil Aricept 44 mGluR5 inhibitors 44 Prospective Randomized 44 Gliadel Wafer 44 rimonabant #mg 44 PrevOnco 44 opioid dependent 44 Ophena 44 Aplidin 44 bevacizumab Avastin ® 44 CoAxia 44 ASSERT 44 multicenter randomized placebo controlled 44 ZYBRESTAT fosbretabulin 44 PPAR gamma agonist 44 darunavir r 44 ATL/TV# 44 GnRH antagonist 44 ACCORD Lipid 44 cells mcL 44 pharmacological interventions 44 NFV 44 Self Expanding Stent 44 tolterodine 44 Alvesco R 44 syndromal 44 Immunotherapeutic 44 email stuartl@rfc.com.au 44 StemEx R 44 multicenter randomized clinical 44 poststroke 44 Angiox R 44 Tavocept 44 Cardiovasc Res 44 Relieve Depression 44 EXJADE 44 IV Busulfex 44 QVAR ® 44 euthymic patients 44 DU #b 44 psychotherapeutic interventions 44 tacrolimus ointment 44 Aptivus ® 44 GRN# 44 NO# [002] 44 selective A2A adenosine receptor 44 VTP 44 TRO# 44 1 # shikrallah@zawya.com 44 Gentamicin Surgical Implant 44 octreotide 44 Vascular Wrap 44 subconjunctival injection 44 postoperative AF 44 XEPLION R 44 SERCA2a 44 Multicenter 44 STEP BD 44 RRMS patients 44 receptor tyrosine kinase inhibitor 44 -2 -3 44 versus +9 44 TAXUS V 44 darunavir ritonavir 44 Angioblast 44 unresectable HCC 44 Acute Decompensated Heart Failure 44 immunomodulatory therapy 44 blinded randomized 44 TriRima 44 RCTs 44 selective androgen receptor modulator 44 subscale scores 44 ABSORB trial 44 titration phase 44 Cypher Stent 44 Vancocin ® 44 hereditary deficiency 44 conjugated equine estrogens 44 AOD# [002] 44 peginterferon 44 ritonavir boosted 44 Teysuno 44 # SELECT 44 ZACTIMA 44 Rotigotine 44 transdermal testosterone 44 Subgroup analyzes 44 LB# [003] 44 methylnaltrexone 44 immunoconjugate 44 LPV r 44 Pivotal Phase II 44 fallopian tube cancers 44 Fenretinide 44 citalopram Celexa 44 LANTUS ® 44 comparator PI r 44 ThermoDox ® 44 RE COVER 44 fluoropyrimidine 44 uremic pruritus 44 transcranial Doppler ultrasound 44 venlafaxine Effexor 44 PROMETA ® 44 rEEG ® 44 Phase 1b clinical 44 OCEANSIDE Helgren 44 Nexavar ® 44 Nanobody 44 plasma cortisol 44 INVEGA SUSTENNA 43 ARIKACE 43 tinzaparin 43 Zyclara 43 DSM IV Axis 43 CardioFit 43 #.#-#.# m [002] 43 EECP R 43 Medidur FA 43 Neuromonics Tinnitus Treatment 43 ART# 43 % Confidence Interval 43 daily subcutaneous injections 43 adjunctive ABILIFY 43 Amrubicin 43 REALITY Trial 43 Generalized Anxiety Disorder 43 Quinamed 43 REVEAL Registry 43 Diamyd R 43 #:#-# [038] 43 efavirenz EFV 43 BARACLUDE r 43 AQ4N 43 CsA 43 Bellicum 43 confirmatory Phase 43 HALO# [002] 43 Ostarine 43 Sonatherm 43 pregabalin 43 RE MODEL 43 octreotide implant 43 subthreshold 43 GHRH 43 Glufosfamide 43 difluprednate 43 Neovasc Reducer 43 ENGAGE AF TIMI 43 therapy CBT 43 Factor VIIa 43 Melphalan 43 -# -# -1 43 EQUIP OB 43 dabigatran etexilate 43 subcutaneously administered 43 Cx# [002] 43 HuMax 43 Myelodysplastic Syndrome MDS 43 PrevOnco ™ 43 Holes UB# 43 neurocognitive deficits 43 RenalGuard System TM 43 PROCRIT R 43 NCCTG 43 fenretinide 43 GEM OS1 43 prospective multicenter 43 neuropathy sensory 43 pramipexole 43 psychosocial interventions 43 antiepileptic medications 43 Endarterectomy 43 dietary modification 43 Pradefovir 43 tenecteplase 43 Bendamustine 43 BioSTAR R 43 Pivotal Trial 43 LTRA 43 randomized controlled trials 43 SEPET TM 43 RISPERDAL ® 43 Irinotecan 43 MBCT 43 ZFP TF 43 Aggressive Drug Evaluation 43 Combo Stent 43 Aurora Kinase 43 Multimeric 43 subcutaneous immunoglobulin 43 randomized clinical 43 IMC A# 43 somatostatin analogue 43 AMD# [003] 43 NN# [001] 43 Psychopharmacology Berl 43 Structured Clinical 43 StemEx 43 EJ MAR# 43 EFFEXOR XR 43 Betus.com 43 aripiprazole 43 Resten NG 43 serotonin reuptake inhibition 43 clopidogrel pretreatment 43 IMPACT DCM clinical 43 rFVIIIFc 43 DSM IV diagnoses 43 TMC# [002] 43 Embolic Protection Device 43 prospective randomized multicenter 43 multicenter phase 43 cognitive behavioral 43 #:# -# [001] 43 Trovax 43 Mipomersen 43 MD FACS FAAP 43 multicenter Phase II 43 calcium antagonist 43 duloxetine Cymbalta 43 edoxaban 43 MIST Therapy 43 RELIANT Trial 43 PF # [001] 43 clopidogrel Plavix 43 Mimpara 43 Severe Sepsis 43 placebo controlled Phase III 43 STENT 43 risperidone Risperdal 43 prospective multicenter randomized 43 Eur J Neurol 42 Dual Opioid 42 LCP Tacro 42 ritonavir boosted lopinavir 42 transfemoral 42 Phase IIIb 42 IABP 42 Urocidin 42 Medtronic CoreValve ® 42 antibody MAb 42 Lucentis monotherapy 42 amnestic MCI 42 Metres TURF 42 Interleukin IL 42 serotonin reuptake inhibitor 42 dialectical behavioral 42 psychometrically sound 42 TQT 42 nonadherence 42 EOquin 42 PANSS scores 42 XIENCE V Everolimus Eluting 42 Phase III psoriasis 42 drug eluting stent DES 42 Atomoxetine 42 biologic DMARDs 42 idiopathic Parkinson disease 42 OZURDEX ® 42 HSP# inhibitor 42 somatic symptoms 42 IMPACT DCM trial 42 Brief Psychiatric 42 vagus nerve stimulation 42 SPORTSBETTING.com lists 42 GBDH 42 GLPG# 42 Cytochrome P# 42 multicenter dose escalation 42 cilostazol 42 multicenter clinical trials 42 Xerecept 42 comorbid disorders 42 Arno Therapeutics 42 amrubicin 42 GetGoal Phase III 42 Emboshield 42 Duloxetine 42 pharmacodynamic profile 42 Fibromyalgia Syndrome 42 ONTARGET R 42 somatostatin analogs 42 Transcranial Magnetic Stimulation TMS 42 Zirgan 42 ft. Loc 42 KAPIDEX 42 Anticalin R 42 oncolytic vaccine 42 interpersonal psychotherapy 42 DX DEC# 42 PROMUS Element Stent 42 UKPDS 42 Harry Palmin President 42 Genzyme Synvisc 42 Edwards SAPIEN valve 42 GWTG Stroke 42 romidepsin 42 iSONEP 42 Cognitive Behavioural Therapy CBT 42 reboxetine 42 Sym# 42 OncoGel 42 Main Outcome Measure 42 SIR Spheres 42 Phase Ib IIa clinical 42 Catheter Ablation 42 ADP receptor antagonist 42 adenotonsillectomy 42 enhanced external counterpulsation 42 HDRS 42 pentostatin 42 bipolar depression 42 Lamotrigine 42 multicentre randomized double 42 Hyperbaric Oxygen Therapy HBOT 42 Cognitive therapy 42 placebo controlled randomized 42 euthymic 42 AGGRASTAT R tirofiban hydrochloride 42 RLY# 42 prodromal symptoms 42 capecitabine Xeloda 42 Bipolar Disorder STEP BD 42 Ranibizumab 42 NCIC CTG 42 TADS 42 STARFlex ® 42 Imprime PGG 42 Vertos 42 Med Assoc 42 Psychodynamic 42 lanreotide 42 DPNP 42 Lung Rx 42 ISTODAX ® 42 Venlafaxine 42 glatiramer acetate Copaxone 42 Zilver PTX stent 42 diabetes mellitus DM 42 JAMA #:#-# 42 transapical 42 FSAD 42 Stuart Laing ph 42 Spheramine 42 Medidur TM FA 42 NMDA antagonist 42 DDHC 42 CorPath 42 SCIT 42 docetaxel cisplatin 42 BetUs 42 paroxetine sertraline 42 ABSORB clinical 42 BMC Musculoskeletal Disorders 42 Keryx Biopharma 42 pawel.sobczak @ thomson.com 42 STOP AF 42 voclosporin 42 systematic desensitization 41 -# Totals [001] 41 intravesical chemotherapy 41 suppl 41 HIFU tumor 41 double blinded placebo 41 subsyndromal 41 antiandrogens 41 buprenorphine naloxone 41 locoregional disease 41 Luteinizing Hormone Releasing Hormone 41 posttest 41 Levacor 41 Luveniq 41 BioNumerik 41 HepDirect prodrug 41 monoclonal anti 41 Neupogen ® 41 steroid refractory 41 clomipramine 41 cholinesterase inhibitor 41 Fracture Intervention Trial 41 transcranial magnetic stimulation TMS 41 FFT X 41 -# -1 41 Hsp# Inhibitor 41 -# -# [005] 41 MedPulser 41 administered subcutaneously 41 Zilver PTX 41 RHUCIN 41 Long Term Efficacy 41 Abbokinase 41 Medtronic CoreValve 41 nonpharmacologic interventions 41 Granted Orphan Drug 41 OMS# 41 Interbody Fusion 41 closing TRIN 41 VIAject ® 41 SpineAlign 41 VBLOC 41 rituximab monoclonal antibody 41 electroconvulsive therapy ECT 41 OAB symptoms 41 relapse prevention 41 Ascendra 41 Feasibility Trial 41 Prolonged Exposure 41 Edoxaban 41 valopicitabine NM# 41 IBMT 41 QVAR R 41 DAS# remission 41 peripheral arterial 41 -8 -# 41 tapentadol IR 41 neuroleptics 41 Virulizin R 41 rTMS 41 Cognitive Behavior Therapy 41 FOLFIRI chemotherapy 41 citalopram 41 vestibular rehabilitation 41 Sumatriptan OS 41 # Email press.services 41 psychodynamic therapy 41 -2 -# 41 Amikacin Inhale 41 randomized Phase III 41 ALISTA 41 Y Y beats 41 Dysport ^ 41 Febuxostat 41 Trinam 41 Resolute DES 41 DAVANAT R 41 Multicenter Automatic Defibrillator Implantation 41 miglustat 41 depressive symptom 41 Induction Chemotherapy 41 GPRD 41 SUPERA stent 41 TRX1 41 By Shikrallah Nakhoul 41 ILUVIEN 41 Bupropion 41 Metricath Gemini 41 Granulocyte Colony Stimulating Factor 41 Symptom severity 41 Mild Cognitive Impairment 41 TAXUS Stent 41 TheraCIM 41 Plasmin 41 CA4P 41 TransMID 41 Delcath PHP System 41 nonpharmacological 41 G CSF 41 Indaflex TM 41 M Vax 41 Systematic Treatment 41 Mimetics 41 meta analytic 41 WBPA 41 multicentre 41 piperacillin tazobactam 41 D Cycloserine 41 Insulin Therapy 41 selective A1 adenosine 41 spinal manipulation 41 laparoscopic radical nephrectomy 41 DAVANAT ® 41 choroidal vasculopathy 41 REFLEX 41 cleavable linker 41 biventricular 41 eC SSRS 41 ASCO Accepted Abstract 41 NICE guideline 41 Blinatumomab 41 humanised monoclonal antibody 41 SFDD 41 pharmacotherapy 41 reuptake inhibitor 41 VESTASYNC 41 systolic hypertension 41 e# e# [001] 40 CATIE 40 Relapse Prevention 40 duloxetine 40 - - [068] 40 mineralocorticoid receptor 40 Brinavess 40 ARG# 40 randomized #:# 40 Schema Therapy 40 NCT# ClinicalTrials.gov 40 rFactor XIII 40 GPi 40 psychoeducational 40 bronchial thermoplasty 40 Inhaled AAT 40 antidepressant therapy 40 multicentre randomized controlled 40 thrombus aspiration 40 Dose Ranging Study 40 #:# -6 40 dacetuzumab 40 Liposomal 40 -#,# -# 40 YEN EJ 40 MetaVision Suite 40 Lixivaptan 40 serotonin reuptake inhibitors 40 Facet Solutions 40 Convivia TM 40 Ophthotech 40 psychopharmacological 40 PTH analogue 40 lorvotuzumab mertansine 40 NOSCAR

Back to home page